<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02367261</url>
  </required_header>
  <id_info>
    <org_study_id>SPI-001</org_study_id>
    <nct_id>NCT02367261</nct_id>
  </id_info>
  <brief_title>A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant</brief_title>
  <acronym>SPI</acronym>
  <official_title>An Open, Prospective, Multi-center Study to Evaluate Bone Loss, the Survival Rate of SPI Implant System and Implant Stability Over a 24 Months, in Patients With Tooth Loss Requiring up to 4 Implants, in Staged Loading Protocol.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alpha - Bio Tec Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alpha - Bio Tec Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current prospective clinical study's aim is to determine ABT's SPI implant survival rate,&#xD;
      crestal interproximal bone resorption during 24 months post implant insertion and to&#xD;
      assimilate the drilling sequence during the clinical use of SPI implants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Survival Rate</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Implant Clinical Survival</condition>
  <condition>Dental Implant Bone Loss</condition>
  <arm_group>
    <arm_group_label>SPI dental implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects implanted with SPI implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SPI implant</intervention_name>
    <description>SPI implant - the original spiral implant</description>
    <arm_group_label>SPI dental implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Men and women over the age of 18 years who need implantation of 1-4 implants.&#xD;
&#xD;
          2. Patients who are able to understand the requirements of the study, and are willing and&#xD;
             able to comply with its instructions and schedules.&#xD;
&#xD;
          3. Patients who had provided written informed consent to participate in the study prior&#xD;
             to any study procedure.&#xD;
&#xD;
          4. Patients in general good health in the opinion of the principal investigator as&#xD;
             determined by medical history and oral examination.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Immediate loaded implants.&#xD;
&#xD;
          2. Patient requiring bone augmentation&#xD;
&#xD;
          3. Treatment with anticoagulant drugs (INR under 1.8) or bisphosphonates.&#xD;
&#xD;
          4. Treatment with anticonvulsants drugs.&#xD;
&#xD;
          5. Untreated Periodontal disease and inability of the patient to maintain reasonable oral&#xD;
             hygiene according to study requirements.&#xD;
&#xD;
          6. Patients with history of alcohol, narcotics or drug abuse.&#xD;
&#xD;
          7. Patients under steroid therapy.&#xD;
&#xD;
          8. Patients receiving radiotherapy, chemotherapy or any other immunosuppressive treatment&#xD;
             or who have been administered radiotherapy in the last 5 years.&#xD;
&#xD;
             Patients through at anytime received radiotherapy to the head and neck region will be&#xD;
             excluded anyway.&#xD;
&#xD;
          9. Metabolic bone disorders and/or bone augmentation.&#xD;
&#xD;
         10. Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia,&#xD;
             granulocytopenia.&#xD;
&#xD;
         11. Degenerative diseases.&#xD;
&#xD;
         12. Osteoradionecrosis.&#xD;
&#xD;
         13. Renal failure.&#xD;
&#xD;
         14. Organ transplant recipients.&#xD;
&#xD;
         15. HIV positive.&#xD;
&#xD;
         16. Malignant diseases.&#xD;
&#xD;
         17. Diseases that compromise the immune system.&#xD;
&#xD;
         18. Unbalanced diabetes mellitus. (HbA1c above 6.5)&#xD;
&#xD;
         19. Psychotic diseases.&#xD;
&#xD;
         20. Hypersensitivity to one of the components of the implant in general and titanium in&#xD;
             particular.&#xD;
&#xD;
         21. Women who are pregnant or lactating.&#xD;
&#xD;
         22. Lack of patient cooperation.&#xD;
&#xD;
         23. Uncontrolled endocrine diseases.&#xD;
&#xD;
         24. Any systemic condition that is unbalanced and therefore precludes surgical procedures.&#xD;
&#xD;
         25. Parafunctional habits.- e.g Bruxism.&#xD;
&#xD;
         26. Temporomandibular joint disease.&#xD;
&#xD;
         27. Various pathologies of the oral mucosa for example: Benign mucous pemphigoid,&#xD;
             desquamative ginigivitis, erosive lichen planus ,malignancy of oral cavity, bolus&#xD;
             erosive diseases of the oral mucosa.&#xD;
&#xD;
         28. Flapless procedures.&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Man, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>West China Hospital of Stomatology, Chengdu, Sichuan China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West China Hospital of Stomatology</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Stomatology</name>
      <address>
        <city>Jinan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Affiliated Stomatology Hospital of Tongji University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stomatology Hospital of Shandong University</name>
      <address>
        <city>Yantai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.alpha-bio.net/il</url>
    <description>Sponsor's site</description>
  </link>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>February 12, 2015</study_first_submitted>
  <study_first_submitted_qc>February 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2015</study_first_posted>
  <last_update_submitted>June 27, 2017</last_update_submitted>
  <last_update_submitted_qc>June 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

